- CONSORT Statement
- CONSORT Statement Extensions
- Evidence underpinning CONSORT
- Accrual and sample size
- Attitudes to trials
- Adverse events (Harms)
- Baseline data
- Blinding
- Compliance
- Early stopping
- Eligibility
- Follow-up
- Funding
- Harms
- Generalizability
- Intention to treat
- Interpretation
- Interventions
- Outcome reporting
- Random allocation
- Recruitment
- Statistical analysis
- Statistical methods
- Trial design issues
- Trial registration
- Uptake of CONSORT by journals
- Impact of and adherence to CONSORT
- Endorsement of CONSORT
Eligibility
Begg CB, Engstrom PF. Eligibility and
extrapolation in cancer clinical trials. J Clin Oncol 1987; 5(6):962-968.
PMID: 3585451
Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people
from clinical research: a descriptive study of published reports. BMJ 1997;
315(7115):1059.
PMID: 9366735
Fuks A, Weijer C, Freedman B, Shapiro S, Skrutkowska M,
Riaz A. A study in contrasts: eligibility criteria in a twenty-year sample of
NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel
Program. Pediatric Oncology Group. J Clin Epidemiol 1998; 51(2):69-79.
PMID: 9474067
George SL. Reducing patient eligibility criteria in cancer
clinical trials. J Clin Oncol 1996; 14(4):1364-1370.
PMID: 8648395
Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly
and women from clinical trials in acute myocardial infarction. JAMA 1992;
268(11):1417-1422.
PMID: 1512909
Howard SC, Algra A, Warlow CP, Rothwell PM. Potential
consequences for recruitment, power, and external validity of requirements for
additional risk factors for eligibility in randomized controlled trials in
secondary prevention of stroke. Stroke 2006; 37(1):209-215.
PMID: 16339480
Rochon PA, Clark JP, Binns MA, Patel V, Gurwitz JH.
Reporting of gender-related information in clinical trials of drug therapy for
myocardial infarction. CMAJ 1998; 159(4):321-327.
PMID: 9732709
Shapiro SH, Weijer C, Freedman B. Reporting the study
populations of clinical trials. Clear transmission or static on the line? J
Clin Epidemiol 2000; 53(10):973-979.
PMID: 11027928
Swanson GM, Bailar JC, III. Selection and description of
cancer clinical trials participants--science or happenstance? Cancer 2002;
95(5):950-959.
PMID: 12209677
Tierney JF, Stewart LA. Investigating patient exclusion
bias in meta-analysis. Int J Epidemiol 2005; 34(1):79-87.
PMID: 15561753
Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility
criteria of randomized controlled trials published in high-impact general
medical journals: a systematic sampling review. JAMA 2007; 297(11):1233-1240.
PMID: 17374817
Page last edited: 05 May 2009
